Home » Topics » Regulatory » Patents

Patents
RSS

Dual 5-HT reuptake inhibitors/5-HT1A antagonists with potential as antidepressants

Aug. 26, 1998

British Biotech claims MMP inhibitors for blocking connective tissue degradation

Aug. 26, 1998

TAN-2421-A1: a novel xanthine derivative with immunomodulating activity

Aug. 26, 1998

International team identifies compounds for treating slow-growing tumors

Aug. 26, 1998

Toray reports kappa agonists for treating dermatological disorders

Aug. 25, 1998

Bristol-Myers Squibb discovers novel maxi-K channel openers

Aug. 25, 1998

More asiatic acid derivatives in development at Dong Kook

Aug. 25, 1998

New agents for pancreatitis in early development at Sankyo

Aug. 25, 1998

Japanese lab describes new agents for asthma and inflammation

Aug. 25, 1998

Sankyo describes NK1/NK2 antagonists for treating asthma

Aug. 25, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Parabilis takes top spot, pricing largest biopharma IPO at $670M
BioWorld
Less than two months after Kailera Therapeutics Inc. made headlines with biopharma’s largest IPO to date, Parabilis Medicines Inc. has come along and surpassed...